Encompass Health Corp
corporate_fare Company Profile
Encompass Health Corp (NYSE:EHC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for EHC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for EHC spans 8-K, 10-Q, 4, DEF 14A.
Recent high-impact activity:
- Encompass Health Reaffirms 2026 Guidance Despite Indefinite Closure of Flood-Damaged Sea Pines Hospital
- Encompass Health 10-Q: Q3 Revenue Up 8.9% to $1.61B, Bad-Debt Reserves Rise on Billing Disruption
- Encompass Health Tops Q3 Estimates and Lifts 2026 Guidance on Revenue, EBITDA and EPS
- Encompass Health Posts 3Q EPS of $1.50
- CEO Mark Tarr Sells $21.7M in Encompass Health Stock Near 52-Week High
Financial Snapshot
Short Interest & Short Volume
2.69 days to coverFINRA reported short interest of 3,613,983 shares in EHC as of the October 30, 2026 settlement, a 9.1% increase from the prior period — about 2.7 days to cover at its recent average daily volume. On November 20, 2026, 51.9% of EHC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for EHC, detected from its recent SEC filings.
Universal Shelf Registration Filed · No Immediate Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →